Wang ZS - Search Results

1

[Clinicopathologic features of hepatocellular carcinoma patients surviving more than 10 years after radical hepatectomy].

Wu LQ, Wang ZS, Cao JY, Hu WY, Han B, Sun CD, Zhang BY, Qiu FB, Zhang S, Yang JY, Cui ZJ. Wu LQ, et al. Among authors: wang zs. Zhonghua Wai Ke Za Zhi. 2017 Feb 1;55(2):130-135. doi: 10.3760/cma.j.issn.0529-5815.2017.02.011. Zhonghua Wai Ke Za Zhi. 2017. PMID: 28162213 Chinese.

2

MicroRNA-92b promotes hepatocellular carcinoma progression by targeting Smad7 and is mediated by long non-coding RNA XIST.

Zhuang LK, Yang YT, Ma X, Han B, Wang ZS, Zhao QY, Wu LQ, Qu ZQ. Zhuang LK, et al. Among authors: wang zs. Cell Death Dis. 2016 Apr 21;7(4):e2203. doi: 10.1038/cddis.2016.100. Cell Death Dis. 2016. PMID: 27100897 Free PMC article.

3

Exportin-T promotes tumor proliferation and invasion in hepatocellular carcinoma.

Lin J, Hou Y, Huang S, Wang Z, Sun C, Wang Z, He X, Tam NL, Wu C, Wu L. Lin J, et al. Mol Carcinog. 2019 Feb;58(2):293-304. doi: 10.1002/mc.22928. Epub 2018 Nov 14. Mol Carcinog. 2019. PMID: 30334580 Free PMC article.

4

Uridine-cytidine kinase 2 upregulation predicts poor prognosis of hepatocellular carcinoma and is associated with cancer aggressiveness.

Huang S, Li J, Tam NL, Sun C, Hou Y, Hughes B, Wang Z, Zhou Q, He X, Wu L. Huang S, et al. Mol Carcinog. 2019 Apr;58(4):603-615. doi: 10.1002/mc.22954. Epub 2019 Jan 22. Mol Carcinog. 2019. PMID: 30556610

5

[On operative approaches in resection of the first rib].

Zhang SF, Wang ZS, Chen WQ. Zhang SF, et al. Among authors: wang zs. Zhonghua Wai Ke Za Zhi. 1985 Jan;23(1):40-1, 63-4. Zhonghua Wai Ke Za Zhi. 1985. PMID: 3979207 Chinese. No abstract available.

6

-173G/C polymorphism in the promoter of MIF is associated with hepatitis B virus infection in a Chinese Han population.

Wang ZS, Yin CC, Han S, Jiang FL, Guo WG, Wu LQ, Liu SH. Wang ZS, et al. Genet Mol Res. 2015 Jul 28;14(3):8532-8. doi: 10.4238/2015.July.28.23. Genet Mol Res. 2015. PMID: 26345783 Free article.

7

Obg-like ATPase 1 (OLA1) overexpression predicts poor prognosis and promotes tumor progression by regulating P21/CDK2 in hepatocellular carcinoma.

Huang S, Zhang C, Sun C, Hou Y, Zhang Y, Tam NL, Wang Z, Yu J, Huang B, Zhuang H, Zhou Z, Ma Z, Sun Z, He X, Zhou Q, Hou B, Wu L. Huang S, et al. Aging (Albany NY). 2020 Feb 11;12(3):3025-3041. doi: 10.18632/aging.102797. Epub 2020 Feb 11. Aging (Albany NY). 2020. PMID: 32045367 Free PMC article.

8

Exosome-related lncRNAs as predictors of HCC patient survival: a prognostic model.

Hou Y, Yu Z, Tam NL, Huang S, Sun C, Wang R, Zhang X, Wang Z, Ma Y, He X, Wu L. Hou Y, et al. Am J Transl Res. 2018 Jun 15;10(6):1648-1662. eCollection 2018. Am J Transl Res. 2018. PMID: 30018707 Free PMC article.

9

A multi-hit therapeutic nanoplatform for hepatocellular carcinoma: Dual stimuli-responsive drug release, dual-modal imaging, and in situ oxygen supply to enhance synergistic therapy.

Chen T, Tam N, Mao Y, Sun C, Wang Z, Hou Y, Xia W, Yu J, Wu L. Chen T, et al. Mater Today Bio. 2022 Jun 23;16:100338. doi: 10.1016/j.mtbio.2022.100338. eCollection 2022 Dec. Mater Today Bio. 2022. PMID: 35847375 Free PMC article.

10

SKA3 Promotes tumor growth by regulating CDK2/P53 phosphorylation in hepatocellular carcinoma.

Hou Y, Wang Z, Huang S, Sun C, Zhao J, Shi J, Li Z, Wang Z, He X, Tam NL, Wu L. Hou Y, et al. Cell Death Dis. 2019 Dec 5;10(12):929. doi: 10.1038/s41419-019-2163-3. Cell Death Dis. 2019. PMID: 31804459 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

478 results

Search Page

Filters